- SS Innovations will showcase its SSi Mantra surgical robotic system at the Society of Robotic Surgery (“SRS”) 2026 Annual Meeting in Florida on July 23-26.
- The presentation will feature a live kidney telesurgery broadcast from India, demonstrating the remote capabilities of the SSi Mantra platform.
- Chairman and CEO Dr. Sudhir Srivastava to participate in multiple conference presentations covering telesurgery, robotic surgery adoption and regulatory developments.
- As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric and telesurgical procedures.
- Approximately 2,100 physicians have already been trained on the platform, which has been used across more than 170 different surgical procedures.
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, will bring its SSi Mantra surgical robotic system to one of the largest annual gatherings of robotic surgery specialists, highlighting the company’s expanding clinical experience and growing focus on remote surgical capabilities. The company announced that the SSi Mantra will be showcased during the Society of Robotic Surgery (“SRS”) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida (https://ibn.fm/FkgsY).
The robotic platform will be demonstrated throughout the conference and featured in multiple technical sessions. One of the event’s focal points will be a live robotic telesurgery in which a partial nephrectomy will be performed remotely by Dr. Amitabh Singh from SS Innovations’ headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
The planned procedure is intended to demonstrate the capabilities of the company’s telesurgery platform in a live educational setting before surgeons, researchers and medical technology professionals attending the conference.
Company Chairman and Chief Executive Officer Dr. Sudhir Srivastava is also scheduled to participate in several presentations and panel discussions covering cardiac telesurgery, robotic surgery adoption, regulatory considerations, global access to robotic care and developments in soft-tissue robotics.
“This influential forum provides us with a prime opportunity to highlight the SSi Mantra’s cutting-edge surgical robotic technology, differentiated features, user friendliness, training capabilities, and cost efficiency,” Dr. Srivastava said. “During this year’s event, I will (…) continue to share SS Innovations’ mission of democratizing global access to advanced surgical robotic care.”
SS Innovations has continued expanding the clinical use of its SSi Mantra platform during the past year. According to the company, more than 12,375 multi-specialty procedures had been completed using the robotic system as of July 6, 2026. Those cases include 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries.
The company also reports that approximately 2,100 physicians have received training on the SSi Mantra platform, which has been used in more than 170 different surgical procedures across multiple specialties. Those figures reflect continued growth in clinical utilization, an important metric for companies developing surgical robotics because expanding physician adoption typically generates additional experience, procedural data and training opportunities.
The SSi Mantra is designed as a modular robotic surgery platform capable of supporting a broad range of minimally invasive procedures. Its architecture includes three to five robotic arms, an open-console surgeon workstation, three-dimensional 4K visualization, integrated imaging capabilities and a suite of more than 40 robotic surgical instruments supporting specialties that include general surgery, urology, gynecology, cardiac surgery, pediatric surgery and ear, nose and throat procedures.
Among the platform’s distinguishing features is the optional SSi MantrAsana tele-surgeon console, which enables surgeons to perform procedures remotely while maintaining functionality comparable to the standard operating console.
Remote surgery remains an emerging segment within robotic medicine. While regulatory, technical and infrastructure challenges continue to shape its adoption, proponents believe telesurgery could eventually expand access to specialized surgical expertise for patients in underserved regions.
SS Innovations has stated that the SSi Mantra is the only surgical robotic platform to have been used for cardiac telesurgery. Although telesurgery continues to evolve and currently represents a relatively small portion of overall robotic surgery activity, the company views the capability as an important component of its long-term technology strategy.
Beyond remote surgery, SS Innovations continues to position the SSi Mantra as a cost-conscious alternative within the broader robotic surgery market. The company says its objective is to make robotic-assisted procedures more affordable and accessible while supporting hospitals that may face financial barriers to adopting existing robotic systems. That strategy combines technology development with physician training, clinical validation and international expansion.
SS Innovations has steadily increased both the number of installed systems and the range of procedures supported by its platform. Earlier this year, the company announced that the SSi Mantra had surpassed 10,500 cumulative procedures, a figure that has continued to grow as adoption expands.
For more information, visit the company’s website at www.SSInnovations.com.
NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII
About QualityStocks
QualityStocks (“QS”) is a specialized communications platform with a focus on private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, QS is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, QS brings its clients unparalleled recognition and brand awareness. QS is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-published: https://www.QualityStocks.com/Disclaimer
QualityStocks
Austin, Texas
www.QualityStocks.com
512.354.7000 Office
Editor@QualityStocks.com
QualityStocks is powered by IBN
